HA
CVS icon

Herold Advisors’s CVS Health CVS Stock Holding History

Herold Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$681K Sell
9,476
-642
-6% -$49.5K 0.15% 144
2025
Q4 		$803K Buy
10,118
+9
+0.1% +$710 0.18% 124
2025
Q3 		$762K Sell
10,109
-867
-8% -$59.4K 0.18% 133
2025
Q2 		$757K Sell
10,976
-714
-6% -$46.8K 0.16% 143
2025
Q1 		$792K Sell
11,690
-687
-6% -$41.1K 0.17% 137
2024
Q4 		$556K Sell
12,377
-5,080
-29% -$285K 0.12% 175
2024
Q3 		$1.1M Sell
17,457
-6,269
-26% -$366K 0.24% 117
2024
Q2 		$1.4M Buy
23,726
+2
+0% +$125 0.32% 84
2024
Q1 		$1.89M Sell
23,724
-241
-1% -$18.4K 0.46% 63
2023
Q4 		$1.89M Buy
23,965
+333
+1% +$23.7K 0.52% 60
2023
Q3 		$1.65M Sell
23,632
-6,010
-20% -$426K 0.5% 59
2023
Q2 		$2.05M Buy
29,642
+3,104
+12% +$221K 0.63% 44
2023
Q1 		$1.97M Buy
26,538
+2,835
+12% +$238K 0.68% 41
2022
Q4 		$2.21M Sell
23,703
-6,738
-22% -$650K 0.94% 27
2022
Q3 		$2.9M Sell
30,441
-170
-0.6% -$16.8K 1.4% 12
2022
Q2 		$2.84M Buy
30,611
+606
+2% +$59.1K 1.26% 16
2022
Q1 		$3.04M Buy
30,005
+18,366
+158% +$1.93M 1.08% 15
2021
Q4 		$1.2M Sell
11,639
-392
-3% -$36.2K 0.47% 75
2021
Q3 		$1.02M Buy
+12,031
New +$1.01M 0.4% 79

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Herold Advisors's CVS Position: Q1 2026 in Review

Herold Advisors reduced its CVS Health (CVS) stake by 6.3% in Q1 2026, selling an estimated $49.5K and leaving 9,476 shares worth $681K. The position accounts for 0.15% of the portfolio, ranked #144.

Herold Advisors first reported a position in CVS in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.04M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Herold Advisors held 9,476 shares of CVS Health worth $681K as of Q1 2026.
  • Herold Advisors sold 642 CVS Health shares in Q1 2026, an estimated $49.5K.
  • CVS Health made up 0.15% of Herold Advisors's portfolio in Q1 2026, its #144 holding.
  • Herold Advisors first reported a position in CVS Health in Q3 2021 and has held it in 19 quarters since.
  • Herold Advisors's CVS Health position peaked at $3.04M in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.